Mumbai, December 24, 2025: Indian equities opened with a mild uptick on Wednesday as strong US growth cues supported risk appetite, but the session stayed choppy as IT stocks weighed and holiday-thinned volumes kept moves contained. In early trade, the Nifty 50 hovered near the 26,200 zone and the Sensex was around 85,600, with most sectors edging higher even as tech stocks slipped.
As the day progressed, the mood turned more cautious. By late afternoon, benchmark indices had slipped into the red, with pharma, IT and select FMCG heavyweights dragging, even as autos, healthcare and infrastructure names provided pockets of support.
What follows is a news-led + analyst-led roundup of top stocks to buy in India today, using only reports, technical calls, and market analysis published on 24.12.2025. This is designed for readers tracking NSE/BSE stocks, intraday opportunities, and short-term positional ideas.
India stock market today: what’s driving sentiment on 24 December 2025
1) Global cues: US growth data lifts risk appetite, but IT drags
A key tailwind for Asian equities (including India) was strong US economic data, which helped sentiment early in the day. However, India’s IT pack underperformed, pressured by US regulatory changes to the H‑1B visa program that favor higher-skilled and higher-paid workers—an important theme for Indian IT services firms and their margins.
2) Liquidity and rates: RBI’s liquidity push in focus
In the background, traders are also tracking the Reserve Bank of India’s liquidity operations. Reuters reported the RBI is set to inject liquidity through a mix of open market operations and a dollar/rupee swap, a move that influenced bond yields and front-end liquidity expectations.
3) Holiday week trading: lower volumes, more stock-specific action
With year-end conditions and holiday-thinned participation, traders have leaned more toward stock-specific catalysts (corporate actions, deals, sector rotations) rather than big index trends—exactly the kind of tape where “stocks in focus” can outperform. Reuters+1
Nifty 50 and Bank Nifty levels to watch today
Multiple market technicians flagged a range-bound setup for the day:
- Nifty 50: immediate support near 26,050; resistance near 26,300 (range-bound bias).
- Another technical view pegged the “next hurdle” zone at 26,250–26,325, with immediate support near 26,050. Goodreturns
- Bank Nifty: consolidation around the 59,300 zone; daily range roughly 59,000–59,800, with bigger breakout levels highlighted above ~59,800 by some analysts.
- A separate market note put support at 26,000 / 25,940 and resistance at 26,235 / 26,300 for the Nifty, reinforcing the range-trading theme.
Top stocks to buy today in India: analyst picks (intraday + short-term)
Below are published analyst recommendations dated 24 December 2025, including stated entry zones, targets and stop-loss levels. These are not “guaranteed outcomes”—they’re trade setups and should be treated as such.
A) Top intraday/short-term ideas (technical setups)
- ITC Ltd (intraday/short-term idea): Buy at ₹407.35, target ₹432, stop-loss ₹396 (double-bottom style bullish setup cited).
- Tata Steel Ltd: Buy at ₹170.90, target ₹194, stop-loss ₹159 (bullish continuation setup cited).
- Dr. Reddy’s Laboratories: Buy at ₹1,283.50, target ₹1,368, stop-loss ₹1,241 (triangle breakout setup cited).
B) Intraday “buy-or-sell” calls (high-risk, tight stops)
- Nykaa: Buy at ₹256, target ₹265, stop-loss ₹248.
- JBM Auto: Buy at ₹250, target ₹270, stop-loss ₹240.
- Balmer Lawrie: Buy at ₹180, target ₹190, stop-loss ₹176.
C) Two more trader-focused picks (momentum continuation theme)
- RailTel Corporation: Buy idea with CMP around ₹358.70, stop-loss ₹342, targets ₹375 / ₹390.
- Apollo Micro Systems: Buy idea with CMP around ₹262.25, stop-loss ₹250, targets ₹275 / ₹285.
Breakout stocks to buy today: five trade ideas from a breakout screen
If you prefer “breakout” style trades (typically short-term and momentum-driven), one widely-circulated list for 24 December 2025 included the following:
- GMR Airports: Buy at ₹530.25, target ₹570, stop-loss ₹512.
- NLC India: Buy at ₹256.10, target ₹275, stop-loss ₹246.
- JK Tyre & Industries: Buy at ₹523.35, target ₹560, stop-loss ₹505.
- Affle (Affle 3i): Buy at ₹1,816.10, target ₹1,945, stop-loss ₹1,750.
- Sarda Energy & Minerals: Buy at ₹519.75, target ₹560, stop-loss ₹500.
“Multiday” picks for today: three more names with defined levels
Another set of “stocks to trade” recommendations for 24 December 2025 highlighted:
- Ashok Leyland: Buy above ₹178, stop-loss ₹174, target ₹187 (multi-day).
- HDFC AMC: Buy above ₹2,712, stop-loss ₹2,670, target ₹2,775 (intraday).
- Dalmia Bharat: Buy above ₹2,065, stop-loss ₹2,035, target ₹2,140 (intraday).
Positional ideas: 30–60 day stock recommendations (beyond intraday)
For investors who prefer a slightly longer trade window (weeks rather than hours), a separate set of recommendations published today included:
- CEAT: Buy near ₹3,940–₹3,900, stop-loss ₹3,765, target ₹4,300 (30–60 days).
- Endurance Technologies: Buy near ₹2,680–₹2,650, stop-loss ₹2,545, target ₹2,850 (30–60 days).
- HPL Electric & Power: Buy near ₹405–₹400, stop-loss ₹375, target ₹460 (30–60 days).
News-driven stocks in focus today (catalysts from 24.12.2025 headlines)
Not every “top stock to buy” idea comes from a chart. Some of today’s most-discussed names have fresh corporate triggers that traders often watch closely.
Coal India: listing plan for subsidiaries
Coal India was among the notable movers after Reuters reported its board gave in-principle approval for listing subsidiaries (South Eastern Coalfields and Mahanadi Coalfields were cited), boosting the stock in early trade.
Ajanta Pharma + Biocon: semaglutide marketing pact (GLP‑1 theme)
Ajanta Pharma rose sharply after signing an agreement with Biocon for marketing semaglutide (a GLP‑1 drug) in multiple overseas markets. Reports today noted Biocon will supply semaglutide to Ajanta for exclusive marketing in 23 countries and semi-exclusive marketing in three countries across Africa/West Asia/Central Asia.
Several reports also tied the move to the broader GLP‑1 opportunity set and semaglutide’s patent expiry in many target markets in March 2026, with commercialization dependent on regulatory approvals.
A Business Standard report added context on the day’s surge, including that the stock hit a multi-month high and discussed how broker commentary viewed the deal’s strategic fit (while noting unit economics still need clarity).
Why this matters beyond one stock: India’s obesity/GLP‑1 race
Reuters also published a wider piece on how Eli Lilly and Novo Nordisk are competing in India’s obesity drug market ahead of expected generic entry, with more Indian pharma companies (including large names) planning to enter after semaglutide-related patent timelines—keeping the GLP‑1 space firmly on traders’ watchlists.
Hindustan Zinc: silver’s record run keeps metals on radar
Metals were also in focus. Moneycontrol’s live coverage noted Hindustan Zinc extended gains as silver continued its record run, with the update citing silver around $72.70/oz and highlighting strong year-to-date performance for the commodity.
Brokerage calls in the spotlight today (reported on 24 December 2025)
Alongside trader-centric levels, some longer-horizon investors track daily brokerage notes for targets and rerating triggers. A Times of India roundup today cited:
- Varun Beverages: BoFA Securities “buy” rating with a target of ₹550, linked to VBL’s acquisition of Twizza in South Africa and the expected operational impact (volume/revenue/EBITDA contribution estimates were referenced). The Times of India
- Century Plywood: Nuvama “buy” rating with a target of ₹1,028, tied to management growth targets and margin/segment outlook described in the report. The Times of India
- Samvardhana Motherson: Nomura “buy” rating with a target of ₹125, linked to an acquisition angle and EPS accretion expectations cited. The Times of India
How to use this “top stocks to buy today” list without getting trapped
Because today’s tape has repeatedly been described as range-bound and liquidity-thinned, discipline matters more than bravado:
- Match the stock to your timeframe. Intraday calls (tight stops) are very different from 30–60 day positional setups.
- Respect key index levels (Nifty ~26,050 support / ~26,300 resistance) because breakouts and breakdowns often decide whether individual trades follow through.
- Keep position size smaller than usual when volumes are thin—slippage risk rises, and fakeouts become common.
- Know the day’s sector drag. If IT and pharma are weak on the day, even strong charts can stall; likewise, news catalysts can overpower sector weakness for specific names.
Disclosure and reader note
This article is for informational and educational purposes and summarizes news reports and analyst calls published on 24 December 2025. It is not personalized investment advice. Always verify prices, liquidity, and corporate updates, and consult a SEBI-registered advisor if needed.
